Phase 4 Studies in the UK Market: Post-Approval Commitments
Phase 4 Studies in the UK Market: Post-Approval Commitments Phase 4 Clinical Trials and Post-Approval Obligations in the United Kingdom Phase 4 clinical studies, often referred to as post-marketing trials, play a critical role in the United Kingdom (UK) pharmaceutical ecosystem. These studies are designed to monitor long-term safety, assess real-world effectiveness, and fulfil regulatory…
Read More “Phase 4 Studies in the UK Market: Post-Approval Commitments” »